Alerts will be sent to your verified email
Verify EmailMEDICO
Medico Remedies
|
Jenburkt Pharma
|
Albert David
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
11.79 % | 18.48 % | 12.32 % |
5yr average Equity Multiplier
|
2.18 | 1.2 | 1.67 |
5yr Average Asset Turnover Ratio
|
1.48 | 0.95 | 0.67 |
5yr Avg Net Profit Margin
|
3.76 % | 16.38 % | 11.52 % |
Price to Book
|
8.58 | 3.05 | 1.21 |
P/E
|
53.83 | 15.3 | 12.32 |
5yr Avg Cash Conversion Cycle
|
34.15 Days | -16.2 Days | -59.38 Days |
Inventory Days
|
52.67 Days | 26.89 Days | 46.72 Days |
Days Receivable
|
107.96 Days | 46.84 Days | 28.39 Days |
Days Payable
|
136.18 Days | 76.62 Days | 118.01 Days |
5yr Average Interest Coverage Ratio
|
9.64 | 75.84 | 90.39 |
5yr Avg ROCE
|
17.25 % | 24.52 % | 15.83 % |
5yr Avg Operating Profit Margin
|
5.84 % | 20.46 % | 11.27 % |
5 yr average Debt to Equity
|
0.3 | 0.03 | 0.01 |
5yr CAGR Net Profit
|
38.44 % | 11.81 % | 31.51 % |
5yr Average Return on Assets
|
5.66 % | 15.36 % | 7.45 % |
Shareholdings
|
|||
Promoter Holding
|
63.79 % | 46.68 % | 62.24 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-9.55 % | 0.95 % | 0.28 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Medico Remedies
|
Jenburkt Pharma
|
Albert David
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|